1291P Hypersensitivity reactions (HR) to selpercatinib in...

Annals of Oncology 2020 / 09 Vol. 31

1291P Hypersensitivity reactions (HR) to selpercatinib in RET fusion+ non-small cell lung cancer (NSCLC) patients (pts) following immune checkpoint inhibition (CPI)

McCoach, C., Tan, D.S.W., Besse, B., Goto, K., Zhu, V.W., Rolfo, C.D., Farajian, S., Potter, L., Kherani, J.F., Soldatenkova, V., Olek, E., Lee, P., Park, K.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
31
Journal:
Annals of Oncology
DOI:
10.1016/j.annonc.2020.08.1605
Date:
September, 2020
File:
PDF, 130 KB
2020
Conversion to is in progress
Conversion to is failed